EKTA B Stock Overview
A medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Elekta AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 66.65 |
52 Week High | SEK 90.00 |
52 Week Low | SEK 64.00 |
Beta | 1.09 |
11 Month Change | -21.59% |
3 Month Change | -20.47% |
1 Year Change | -20.14% |
33 Year Change | -48.15% |
5 Year Change | -50.99% |
Change since IPO | 387.68% |
Recent News & Updates
Recent updates
Elekta (STO:EKTA B) Hasn't Managed To Accelerate Its Returns
Jun 19What Elekta AB (publ)'s (STO:EKTA B) P/E Is Not Telling You
May 24Elekta AB (publ) (STO:EKTA B) Shares Could Be 29% Below Their Intrinsic Value Estimate
May 12When Should You Buy Elekta AB (publ) (STO:EKTA B)?
Apr 03Is Elekta (STO:EKTA B) A Risky Investment?
Mar 18Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
Feb 22Why Investors Shouldn't Be Surprised By Elekta AB (publ)'s (STO:EKTA B) P/E
Feb 20Return Trends At Elekta (STO:EKTA B) Aren't Appealing
Feb 08Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 37% Above Its Share Price
Jan 03Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Dec 18Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Dec 01Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Nov 11Elekta (STO:EKTA B) Has Some Way To Go To Become A Multi-Bagger
Nov 09Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Oct 28Is Now The Time To Look At Buying Elekta AB (publ) (STO:EKTA B)?
Oct 26Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Oct 14An Intrinsic Calculation For Elekta AB (publ) (STO:EKTA B) Suggests It's 41% Undervalued
Sep 23Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Sep 08Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Aug 25Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Aug 10Is There Now An Opportunity In Elekta AB (publ) (STO:EKTA B)?
Jul 21Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Jul 08Is There An Opportunity With Elekta AB (publ)'s (STO:EKTA B) 25% Undervaluation?
Jun 13Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
May 28Here's Why Elekta (STO:EKTA B) Can Manage Its Debt Responsibly
Apr 02Investors Can Find Comfort In Elekta's (STO:EKTA B) Earnings Quality
Mar 04Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 57% Above Its Share Price
Feb 27Elekta's (STO:EKTA B) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 15Elekta (STO:EKTA B) Will Pay A Larger Dividend Than Last Year At SEK1.20
Feb 01What Does Elekta AB (publ)'s (STO:EKTA B) Share Price Indicate?
Jan 23These 4 Measures Indicate That Elekta (STO:EKTA B) Is Using Debt Reasonably Well
Dec 27Elekta's (STO:EKTA B) Upcoming Dividend Will Be Larger Than Last Year's
Dec 14Elekta (STO:EKTA B) Is Reinvesting At Lower Rates Of Return
Dec 09Elekta's (STO:EKTA B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 23Elekta's (STO:EKTA B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 09Elekta (STO:EKTA B) Will Pay A Larger Dividend Than Last Year At SEK1.20
Oct 26What Is Elekta AB (publ)'s (STO:EKTA B) Share Price Doing?
Oct 17Elekta's (STO:EKTA B) Dividend Will Be Increased To SEK1.20
Sep 19Elekta (STO:EKTA B) Has Announced That It Will Be Increasing Its Dividend To SEK1.20
Aug 28Is Elekta (STO:EKTA B) A Risky Investment?
Aug 22Elekta's (STO:EKTA B) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 08Elekta's (STO:EKTA B) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 10Return Trends At Elekta (STO:EKTA B) Aren't Appealing
Jul 07When Should You Buy Elekta AB (publ) (STO:EKTA B)?
Jun 23Shareholder Returns
EKTA B | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 2.6% | 0.3% | 0.2% |
1Y | -20.1% | -2.9% | 12.6% |
Return vs Industry: EKTA B underperformed the Swedish Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: EKTA B underperformed the Swedish Market which returned 14.1% over the past year.
Price Volatility
EKTA B volatility | |
---|---|
EKTA B Average Weekly Movement | 6.3% |
Medical Equipment Industry Average Movement | 7.2% |
Market Average Movement | 5.9% |
10% most volatile stocks in SE Market | 12.3% |
10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: EKTA B's share price has been volatile over the past 3 months.
Volatility Over Time: EKTA B's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1972 | 4,500 | Gustaf Salford | elekta.com |
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care.
Elekta AB (publ) Fundamentals Summary
EKTA B fundamental statistics | |
---|---|
Market cap | SEK 25.47b |
Earnings (TTM) | SEK 1.30b |
Revenue (TTM) | SEK 18.12b |
19.6x
P/E Ratio1.4x
P/S RatioIs EKTA B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EKTA B income statement (TTM) | |
---|---|
Revenue | SEK 18.12b |
Cost of Revenue | SEK 11.32b |
Gross Profit | SEK 6.80b |
Other Expenses | SEK 5.50b |
Earnings | SEK 1.30b |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
Jul 05, 2024
Earnings per share (EPS) | 3.41 |
Gross Margin | 37.55% |
Net Profit Margin | 7.19% |
Debt/Equity Ratio | 55.0% |
How did EKTA B perform over the long term?
See historical performance and comparison